Results 221 to 230 of about 8,980,898 (399)
Institutions and the Resource Curse
, 2006 Halvor Mehlum, K. Moene, Ragnar Torvik
semanticscholar +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases. [PDF]
PLoS OneZeng Z, Sathasivam S, Xin J, Zhao H.
europepmc +1 more source
Building Infrastructure for HIV/AIDS and Mental Health Research at Institutions Serving Minorities
, 2009 Richard Yanagihara +2 more
openalex +1 more source
Molecular Oncology, EarlyView.This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Percutaneous nephrolithotomy of horseshoe kidney: Our institutional experience
, 2018 Prasun Pramanik +4 more
openalex +1 more source